Quantesla Medical Technologies Profile
Key Indicators
- Authorised Capital ₹ 4.80 M
- Paid Up Capital ₹ 4.72 M
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.00 M
- Revenue Growth -6.21%
- Profit Growth 76.20%
- Ebitda 1531.90%
- Net Worth -1.69%
- Total Assets 11.19%
About Quantesla Medical Technologies
Quantesla Medical Technologies Private Limited (QMTPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 January 2016 (Nine years and one month 5 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.80 M and a paid-up capital of Rs 4.72 M.
The company currently has active open charges totaling ₹6.00 M.
Mandar Dharmadhikari and Gauri Dharmadhikari serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33309PN2016PTC158018
- Company No.
158018
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Quantesla Medical Technologies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mandar Dharmadhikari  | Director | 19-Jan-2016 | Current |
| Gauri Dharmadhikari | Director | 19-Jan-2016 | Current |
Financial Performance of Quantesla Medical Technologies.
Quantesla Medical Technologies Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 6.21% decrease. The company also saw a substantial improvement in profitability, with a 76.2% increase in profit. The company's net worth dipped by a decrease of 1.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quantesla Medical Technologies?
In 2020, Quantesla Medical Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹6.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jul 2018 | State Bank Of India | ₹6.00 M | Open |
How Many Employees Work at Quantesla Medical Technologies?
Unlock and access historical data on people associated with Quantesla Medical Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quantesla Medical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quantesla Medical Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.